You are here

Roche

Apple, JNJ, Roche among companies selected for FDA digital health precertification pilot

BioPharma Dive

Thu, 09/28/17 - 09:45 am

digital healthcare

AbbVie, Roche to seek broader market for leukemia drug after trial success

BioPharma Dive

Tue, 09/19/17 - 10:23 pm

clinical trials

chronic lymphocytic leukemia

FDA Clears Biotech Drug Copycats, But Buying Them Isn’t So Easy

Bloomberg

Mon, 09/18/17 - 09:41 am

Samsung Bioepis first to secure EMA backing for Herceptin biosimilar

BioPharma Dive

Mon, 09/18/17 - 09:23 am

Samsung Bioepis

FDA adds two Roche studies to its growing list of partial clinical holds in wake of Keytruda deaths

Endpoints

Sat, 09/16/17 - 12:06 pm

clinical trials

Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?

Motley Fool

Sat, 09/16/17 - 12:05 pm

Teva Pharmaceutical

Unitedhealthcare Group

Bristol-Myers Squibb

FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin

Endpoints

Fri, 09/15/17 - 09:14 am

FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports

Fierce Pharma

Tue, 09/12/17 - 10:00 pm

clinical trials

Roche gets hit with another big R&D setback as a prospective AMD blockbuster flops in PhIII

Endpoints

Sat, 09/9/17 - 02:14 pm

An accurate analysis of the differences between Swiss companies Roche and Novartis

GoInPharma

Sat, 09/9/17 - 01:22 pm

Parkinson's Now a Hot Therapeutic Area: What's Up Lately?

Yahoo/Zacks.com

Sat, 09/2/17 - 11:11 am

Parkinson's Disease

Teva Pharmaceutial

Adamas Pharmaceuticals

Best Pharma Stocks Based on R&D Spending

Motley Fool

Mon, 08/28/17 - 09:27 am

Under fire from Shire, Roche grabs the VIP lane for top drug prospect emicizumab

Endpoints

Thu, 08/24/17 - 09:53 am

Personal turf is ‘out,’ community workplaces are ‘in’ at the new Roche neighborhood

Endpoints

Mon, 08/21/17 - 11:24 am

An analysis of 2017 first half for pharmaceutical industry

GoInPharma

Sat, 08/19/17 - 10:51 am

pharma industry

Bristol-Myers Squibb

Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers

Fierce Pharma

Thu, 08/17/17 - 11:48 pm

multiple sclerosis

Teva Pharmaceutical

Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing

Drug Delivery Business News

Thu, 08/17/17 - 10:04 am

drug development

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

Thu, 08/17/17 - 09:57 am

drug development

Alzheimer's disease

Drug developers face increasingly risky tightrope walk between top-line results and hard data

Endpoints

Tue, 08/15/17 - 10:57 am

drug development

clinical trials

late stage data

Pharma's giants, new and old, tell more tales than their numbers show

Fierce Pharma

Fri, 08/11/17 - 11:16 am

Bristol-Myers Squibb

Pages